Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Terrain Biosciences launches from stealth today as the world's first RNA design-build company, using advanced AI and its ...

AI creates anti-cancer molecules for proteins that previously could not be targeted pharmacologically by leveraging quantum ...

The model has uncovered a hidden layer of molecular code that shapes biological organization, adding new dimensions of ...

Nature Medicine has been chronicling advances in medical technology and health care. To mark the journal’s 30th anniversary, each month ...

AI is increasingly being adopted across healthcare and in 2025, it will be a driving force behind a smarter, nimbler, and ...

Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.

Its deal with the US-based AI-driven drug design and development company will see Cloud design novel small-molecule agents to GSK-specified targets. Ed Addison, CEO of Cloud Pharmaceuticals ...

His team harnesses advanced computational technologies, including AI, with the aim of enhancing the discovery, design, optimization and synthesis of small molecules to be developed into innovative ...

Insilico Medicine (“Insilico”) announces that the team, with the support of its generative chemistry engine, has developed a ...

an AI model trained on billions of natural protein sequences, to design a functional protein beyond evolutionary constraints. The development is expected to accelerate medical research, drug ...

Explore the transformative power of responsible AI across industries, emphasizing security, MLOps, and compliance. As AI ...